Publications
Detailed Information
Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dae Sik | - |
dc.contributor.author | Na, Dong Gyu | - |
dc.contributor.author | Kim, Keon Ha | - |
dc.contributor.author | Kim, Ji-hoon | - |
dc.contributor.author | Yun, Bo La | - |
dc.contributor.author | Chang, Kee-Hyun | - |
dc.contributor.author | Kim, Eunhee | - |
dc.date.accessioned | 2012-07-02T05:42:38Z | - |
dc.date.available | 2012-07-02T05:42:38Z | - |
dc.date.issued | 2009-05 | - |
dc.identifier.citation | RADIOLOGY; Vol.251 2; 467-475 | ko_KR |
dc.identifier.issn | 0033-8419 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78087 | - |
dc.description.abstract | Purpose: To determine retrospectively whether unenhanced computed tomographic (CT) images of the brain have added value in distinguishing tumefactive demyelinating lesions (TDLs) from primary glioma or central nervous system (CNS) lymphoma, compared with conventional contrast material -enhanced magnetic resonance(MR) images only. Materials and Methods: This study was approved by the institutional review board, and informed consent was waived. Unenhanced CT and MR images in 15 patients with TDLs (seven women, eight men; mean age, 42 years; range, 27-57 years) and 48 patients with primary brain tumor (27 women, 21 men; mean age, 48 years; range, 19-70 years; 10 lymphomas, 38 gliomas) were retrospectively reviewed. The CT attenuation of regions that were enhanced or unenhanced at MR imaging was visually categorized into three grades, and CT attenuation values were determined quantitatively. The diagnostic accuracy of MR imaging for differentiating TDLs from tumors was compared with that of MR imaging plus CT. Results: The following MR imaging features were found more frequently in patients with TDL than in those with brain tumor: incomplete rim enhancement, mixed T2-weighted iso- and hyperintensity of enhanced regions, absence of a mass effect, and absence of cortical involvement (all P values < .05). CT hypoattenuation of MR enhanced regions was observed in 14 (93%) of 15 patients with TDL but in only two (4%) of 48 patients with tumor. The CT attenuation of MR enhanced regions was significantly lower for patients with TDL than for those with tumor (P < .001). The diagnostic accuracy of CT plus MR imaging was significantly higher than that of MR imaging alone (97% vs 73.0%, respectively; P < .001), and the diagnostic accuracy of CT was significantly higher than that of unenhanced T1-weighted MR imaging (95% vs 63%, P < .001). Conclusion: Unenhanced CT plus MR imaging was more accurate for distinguishing TDLs from glioma or CNS lymphoma than contrast-enhanced MR imaging alone. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | RADIOLOGICAL SOC NORTH AMERICA | ko_KR |
dc.title | Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김대식 | - |
dc.contributor.AlternativeAuthor | 나동규 | - |
dc.contributor.AlternativeAuthor | 김건하 | - |
dc.contributor.AlternativeAuthor | 김지훈 | - |
dc.contributor.AlternativeAuthor | 김은희 | - |
dc.contributor.AlternativeAuthor | 윤보라 | - |
dc.contributor.AlternativeAuthor | 장기현 | - |
dc.identifier.doi | 10.1148/radiol.2512072071 | - |
dc.citation.journaltitle | RADIOLOGY | - |
dc.description.citedreference | Omuro AMP, 2006, LANCET NEUROL, V5, P937 | - |
dc.description.citedreference | Schwartz KM, 2006, NEURORADIOLOGY, V48, P143, DOI 10.1007/s00234-005-0024-5 | - |
dc.description.citedreference | Selkirk SM, 2005, MULT SCLER, V11, P731, DOI 10.1191/1352458505ms1214cr | - |
dc.description.citedreference | Sagiuchi T, 2005, ANN NUCL MED, V19, P603 | - |
dc.description.citedreference | Enzinger C, 2005, MULT SCLER, V11, P135, DOI 10.1191/1352458505ms1145oa | - |
dc.description.citedreference | Tan HM, 2004, BRIT J RADIOL, V77, P153, DOI 10.1259/bjr/26682607 | - |
dc.description.citedreference | Saindane AM, 2002, AM J NEURORADIOL, V23, P1378 | - |
dc.description.citedreference | Khoshyomn S, 2002, J NEUROL NEUROSUR PS, V73, P85 | - |
dc.description.citedreference | Rovira A, 2002, AM J NEURORADIOL, V23, P989 | - |
dc.description.citedreference | Bernarding J, 2002, J MAGN RESON IMAGING, V15, P96, DOI 10.1002/jmri.10045 | - |
dc.description.citedreference | Cha S, 2001, AM J NEURORADIOL, V22, P1109 | - |
dc.description.citedreference | Nusbaum AO, 2000, AM J ROENTGENOL, V175, P821 | - |
dc.description.citedreference | Masdeu JC, 2000, NEUROLOGY, V54, P1427 | - |
dc.description.citedreference | Bitsch A, 1999, AM J NEURORADIOL, V20, P1619 | - |
dc.description.citedreference | Ernst T, 1998, NEUROLOGY, V51, P1486 | - |
dc.description.citedreference | van Waesberghe JHTM, 1998, AM J NEURORADIOL, V19, P675 | - |
dc.description.citedreference | Bruck W, 1997, ANN NEUROL, V42, P783 | - |
dc.description.citedreference | Dagher AP, 1996, NEURORADIOLOGY, V38, P560 | - |
dc.description.citedreference | Masdeu JC, 1996, J NEUROIMAGING, V6, P104 | - |
dc.description.citedreference | LOEVNER LA, 1995, AM J NEURORADIOL, V16, P1473 | - |
dc.description.citedreference | CHAKRABORTTY S, 1995, SURG NEUROL, V43, P591 | - |
dc.description.citedreference | KATZ D, 1993, ANN NEUROL, V34, P661 | - |
dc.description.citedreference | KEPES JJ, 1993, ANN NEUROL, V33, P18 | - |
dc.description.citedreference | NESBIT GM, 1991, RADIOLOGY, V180, P467 | - |
dc.description.citedreference | OTSUKA SI, 1989, J COMPUT ASSIST TOMO, V13, P674 | - |
dc.description.tc | 6 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.